Navigation Links
New Drug May Work Better Against Chemo Side Effects
Date:1/8/2009

Japanese testing reveals longer protection from nausea and vomiting

THURSDAY, Jan. 8 (HealthDay News) -- A drug that better prevents the nausea and vomiting that commonly follows chemotherapy treatment for cancer may be on the horizon, Japanese researchers report.

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo, but is even better at preventing those side effects in the first five days.

In the phase III trial, about three-fourths of the people given either drug (both given in combination with dexamethasone) did not experience nausea and vomiting in the 24 hours immediately after receiving a chemotherapy regimen that included drugs most likely to cause vomiting -- cisplatin or a combination of anthracycline and cyclophosphamide, according to the study. However, nearly 57 percent of those on palonosetron avoided the ill effects in the first five days after treatment, compared with about 44 percent who had been given the standard granisetron regimen.

The study, which was released online and will appear in the February issue of The Lancet Oncology, reported similar safety records for the two drugs.

More information

The National Cancer Institute has more about chemotherapy side effects.

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009



-- Kevin McKeever



SOURCE: The Lancet Oncology, news release, Jan. 7, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses
2. Low-carb diets prove better at controlling type 2 diabetes
3. A Better Method of Kidney Storage
4. Walk Your Way to Better Health in 2009
5. New Product Makes Loose Dentures Fit Better
6. Coated Stents Better Than Bare Metal Ones in Short Run
7. Better patient outcomes with drug eluting stents
8. National rates of co-occurring substance use and mental disorders call for better service integration
9. Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation
10. Immune System Works Better at Night
11. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug May Work Better Against Chemo Side Effects
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, a full ... beneficiary of their ongoing community enrichment program. The current campaign fundraises for Angels ... are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... executive networking and relationship-marketing firm, announced today that nominations will be accepted ... Executive® (ISE®) West Awards. , Awards include the Information Security Executive® ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... a wide variety of organizations. DocuSyst provides a cloud hosted environment for ... Some installations include integration with various 3rd party applications using the FileHold web ...
(Date:2/8/2016)... MD (PRWEB) , ... February 08, 2016 , ... ... is excited to share this important news! AHCC and the Home Health and ... Coding Clinic, CMS' designee for official ICD coding guidance and clarifications, to address ...
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... YORK, Pa. , Feb. 8, 2016  Unilife Corporation ... developer and supplier of injectable drug delivery systems, today announced ... and six months ended December 31, 2015 after market close ... not scheduled a conference call to discuss these financial results.  ... About Unilife Corporation --> About Unilife ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
(Date:2/8/2016)... Feb. 8, 2016  CTI BioPharma Corp. (CTI BioPharma) ... written communication from the U.S. Food and Drug Administration ... placed a partial clinical hold on the clinical studies ... application for pacritinib. This clinical hold impacts part of ... and will also affect planned clinical trials. ...
Breaking Medicine Technology: